Clinical trial
A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young…
NCT00006280 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00006280 |
|---|---|
| Title | A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis |
| Official title | A Phase II Multicenter Randomized Trial of Tobramycin for Inhalation in Young Children With Cystic Fibrosis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | National Center for Research Resources (NCRR) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Tobramycin for Inhalation |
| Enrollment | 98 |
| Start date | Feb 1, 2000 |
| Completion | Feb 1, 2002 |
| First posted | Sep 12, 2000 |
| Last update posted | Mar 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: